Shuttle Pharma completes $9.6M merger with United Dogecoin, closes $9.6M PIPE financing

Filed May 7, 2026 · Period ending May 1, 2026 · ~2 min read

Key Changes

• high

  Completed merger with United Dogecoin Inc. on May 6, 2026, issuing 8,403 shares of Series B-1 preferred stock convertible into 33.9M common shares at $1.24/share, subject to stockholder approval. Former United Dogecoin shareholders may receive up to 122.9M additional pre-funded warrants upon milestone achievement.

  Item 1.01: Merger Agreement verify on EDGAR →
• high

  Closed $9.55M PIPE financing through issuance of 1,910 shares of Series B-2 preferred stock convertible into 9.3M common shares at $1.03/share, plus warrants for up to 100% of underlying shares exercisable for three years. Additional 31.5M pre-funded warrants possible if milestones are met.

  Item 1.01: PIPE Financing verify on EDGAR →
• high

  Appointed Ryan Trasolini as Co-CEO effective May 4, 2026, following merger completion. Trasolini has been CEO of United Dogecoin since December 2025 and is a founding shareholder with prior investment experience in Sesh Products and US Bitcoin Corporation.

  Item 5.02: Officer Appointment verify on EDGAR →